Endocarditis in the 21(st) Century
Abstract
Endocarditis still carries a poor prognosis despite improvement in preventive strategies and advances in diagnosis and also in treatment. Epidemiology of infective endocarditis (IE) has changed in late years. Contemporary antibiotic overuse determines antibiotic resistance against microorganisms involved in IE. Prophylaxis principles have been changed and restricted in order to avoid excessive antibiotic use and unfounded costs. Current guidelines are often based on expert opinion because of the low incidence of the disease, the absence of randomized trials, and the limited number of meta-analyses. The present review will focus on current changes in epidemiology, prophylaxis, diagnosis and treatment options.
Keywords: epidemiology; infective endocarditis; prophylaxis; treatment options.
Conflict of interest statement
I undersign, Monica Mariana Baluta, certificate that I do not have any financial or personal relationships that might bias the content of this work.
References
-
- Lerner PI, Weinstein L. Infective endocarditis in the antibiotic era. N Engl J Med. 1966;274:199–199. - PubMed
-
- Fowler VG, Scheld WM, Bayer AS. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practices of Infectious Diseases 6th ed. Elsevier Churchill Livingstone; 2005. Endocarditis and intravascular infections. pp. 975–1021.
-
- Bruno Hoen, Pilar Tornos, Habib G, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the ESC. Eur Heart J. 2009;30:2369–2413. - PubMed
-
- Hoen B, Alla F, Selton-Suty C, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288:75–81. - PubMed
LinkOut - more resources
Full Text Sources